These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 17514183)
1. Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial. Villarreal G; Calais LA; Cañive JM; Lundy SL; Pickard J; Toney G Psychopharmacol Bull; 2007; 40(2):6-18. PubMed ID: 17514183 [TBL] [Abstract][Full Text] [Related]
2. An open-label assessment of aripiprazole in the treatment of PTSD. Robert S; Hamner MB; Durkalski VL; Brown MW; Ulmer HG Psychopharmacol Bull; 2009; 42(1):69-80. PubMed ID: 19204652 [TBL] [Abstract][Full Text] [Related]
3. An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants. Youssef NA; Marx CE; Bradford DW; Zinn S; Hertzberg MA; Kilts JD; Naylor JC; Butterfield MI; Strauss JL Int Clin Psychopharmacol; 2012 Jul; 27(4):191-6. PubMed ID: 22475888 [TBL] [Abstract][Full Text] [Related]
5. An open-label study of mirtazapine as treatment for combat-related PTSD. Alderman CP; Condon JT; Gilbert AL Ann Pharmacother; 2009 Jul; 43(7):1220-6. PubMed ID: 19584388 [TBL] [Abstract][Full Text] [Related]
6. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study. Lin CH; Lin SH; Jang FL J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699 [TBL] [Abstract][Full Text] [Related]
7. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial. McElroy SL; Suppes T; Frye MA; Altshuler LL; Stanford K; Martens B; Leverich GS; Post RM; Keck PE J Affect Disord; 2007 Aug; 101(1-3):275-81. PubMed ID: 17229469 [TBL] [Abstract][Full Text] [Related]
8. Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder. Bartzokis G; Lu PH; Turner J; Mintz J; Saunders CS Biol Psychiatry; 2005 Mar; 57(5):474-9. PubMed ID: 15737661 [TBL] [Abstract][Full Text] [Related]
9. A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression. Dunn RT; Stan VA; Chriki LS; Filkowski MM; Ghaemi SN J Affect Disord; 2008 Sep; 110(1-2):70-4. PubMed ID: 18272230 [TBL] [Abstract][Full Text] [Related]
10. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials. Glick ID; Mankoski R; Eudicone JM; Marcus RN; Tran QV; Assunção-Talbott S J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder. Bellino S; Paradiso E; Bogetto F Psychiatry Res; 2008 Nov; 161(2):206-12. PubMed ID: 18848360 [TBL] [Abstract][Full Text] [Related]
12. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features. Trivedi MH; Thase ME; Fava M; Nelson CJ; Yang H; Qi Y; Tran QV; Pikalov A; Carlson BX; Marcus RN; Berman RM J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475 [TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study. Kwon JS; Jang JH; Kang DH; Yoo SY; Kim YK; Cho SJ; Psychiatry Clin Neurosci; 2009 Feb; 63(1):73-81. PubMed ID: 19154213 [TBL] [Abstract][Full Text] [Related]
14. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study. Keck PE; Orsulak PJ; Cutler AJ; Sanchez R; Torbeyns A; Marcus RN; McQuade RD; Carson WH; J Affect Disord; 2009 Jan; 112(1-3):36-49. PubMed ID: 18835043 [TBL] [Abstract][Full Text] [Related]
15. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline. Brady KT; Clary CM Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296 [TBL] [Abstract][Full Text] [Related]
16. Open trial of nefazodone for combat veterans with posttraumatic stress disorder. Garfield DA; Fichtner CG; Leveroni C; Mahableshwarkar A J Trauma Stress; 2001 Jul; 14(3):453-60. PubMed ID: 11534877 [TBL] [Abstract][Full Text] [Related]
17. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study. Findling RL; Nyilas M; Forbes RA; McQuade RD; Jin N; Iwamoto T; Ivanova S; Carson WH; Chang K J Clin Psychiatry; 2009 Oct; 70(10):1441-51. PubMed ID: 19906348 [TBL] [Abstract][Full Text] [Related]
18. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies. Thase ME; Jonas A; Khan A; Bowden CL; Wu X; McQuade RD; Carson WH; Marcus RN; Owen R J Clin Psychopharmacol; 2008 Feb; 28(1):13-20. PubMed ID: 18204335 [TBL] [Abstract][Full Text] [Related]
19. Young mania rating scale line item analysis in pediatric subjects with bipolar I disorder treated with aripiprazole in a short-term, double-blind, randomized study. Mankoski R; Zhao J; Carson WH; Mathew SJ; Forbes RA J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):359-64. PubMed ID: 21823911 [TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease. Streim JE; Porsteinsson AP; Breder CD; Swanink R; Marcus R; McQuade R; Carson WH Am J Geriatr Psychiatry; 2008 Jul; 16(7):537-50. PubMed ID: 18591574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]